<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2015-12-28</publicationDate>
    
        <volume>8</volume>
        <issue>2</issue>

 
    <startPage>1165</startPage>
    <endPage>1172</endPage>

	 
      <doi>10.13005/bpj/872</doi>
        <publisherRecordId>6110</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Evaluation of the Relation between Lymph Node Status and Estrogen and Progesterone Receptors Status in Breast Cancer Patients in Ahvaz Hospitals</title>

    <authors>
	 


      <author>
       <name>Amir Ahmad Salmasi</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Abdolhassan Talaeizadeh</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Mehrnoosh Esmaeili</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Surgery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliationName>
    

		
		<affiliationName affiliationId="2">School of Medicine Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Breast cancer is one of the most common cancers in Iranian women. Estrogen and
progesterone receptors have been described as a prognostic factor in breast cancer. Axillary
lymph node status is also one of the most powerful prognostic factors for patients with breast
cancer. The relationship between Estrogen receptor (ER) and progesterone receptor (PR), and
axillary lymph node is still controversial. This study aims to investigate the relationship of ER and
PR with axillary lymph node among women with breast cancer. Estrogen and progesterone
receptors were evaluated by immunohistochemistry assessments in 200 breast cancer patients.
Statistical comparison was performed between ER and PR and nodal status. Of the 200 carcinoma
tissue samples (mean age. 51.34 years), 133 cases (66.5%) were positive for estrogen receptor,
of them 94 cases (70.7%) were positive for axillary nodal involvement. Sixty seven cases (33.5%)
were negative for ER, of them 41 cases (61.2%) were positive for axillary nodal involvement. One
hundred-eighteen cases (59%) were positive for progesterone receptor, of them 82 cases (69.5%)
were positive for axillary nodal involvement. Eighty two cases (41%) were negative for PR, of them
53 cases (64.6%) were positive for axillary nodal involvement. There is no significant relationship
between ER and axillary nodal involvement (P=0.397). In addition, there is no significant relationship
between PR and axillary lymph node involvement (P: 0.825). There is no relationship between ER
and PR status and axillary nodal involvement.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol8no2/evaluation-of-the-relation-between-lymph-node-status-and-estrogen-and-progesterone-receptors-status-in-breast-cancer-patients-in-ahvaz-hospitals/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Estrogen receptor</keyword>
      

      
        <keyword> Progesterone receptor</keyword>
      

      
        <keyword> Breast cancer</keyword>
      

      
        <keyword> Axillary lymph node</keyword>
      
</keywords>
  </record>
</records>